|Tu Du Obstetrics and Gynecology Hospital in HCM City will begin to use HPV testing for screening of cervical cancer.— Photo nld
HCM CITY (VNS)— Tu Du Obstetrics and Gynecology Hospital in HCM City will begin to use HPV testing for screening of cervical cancer.
The virus is the second leading cause of cancer among Vietnamese women after breast cancer, with incidence rates of 9.5-13 per 100,000, according to health officials.
"HPV16 or HPV18 genotyping are the riskiest types that account for 70 per cent of cervical cancer cases," said Le Quang Thanh, director of the hospital.
Besides Papanicolaou screening (Pap screening) and liquid-based cytology, the hospital will use human papillomavirus (HPV) testing for cervical cancer screening this year.
"HPV testing is more sensitive and less specific than Pap testing," said Philip E. Castle, executive director of the Global Cancer Initiative and CEO of the Global Coalition Against Cervical Cancer.
|"HPV testing is more sensitive and less specific than Pap testing," said Philip E. Castle, executive director of the Global Cancer Initiative and CEO of the Global Coalition Against Cervical Cancer.— VNS Photo
The Ministry of Health is working with Roche Vietnam Co. Ltd., and three major hospitals, including the National Hospital for Obstetric and Gynecology, Tu Du Obstetrics and Gynecology Hospital and Hung Vuong Obstetrics and Gynecology Hospital, to develop a new cervical cancer screening programme with HPV testing.
HCM City led the country in cervical cancer incidence rates, with 14-16 per 100,000 women, Thanh said.
"More than 5,100 new cases of cervical cancer are reported nationwide and 2,400 women die from the disease every year," he said at a conference held on Tuesday.
This means seven women in Viet Nam die from cervical cancer every day, most of them are aged 40 to 75.
A Pap screen is done every year to three years, with the interval between tests depending on the age of the woman. — VNS